The Hong Kong Polytechnic University, Department of Rehabilitation Sciences
Hong Kong
Location status: Recruiting
NCT Number: NCT07497334
The goal of this clinical trial is to explore the effects of intermittent theta burst stimulation (iTBS) primed with theta burst stimulation (cTBS), on top of aerobic exercise, on cognitive function, mobility, and brain activity in older adults with cognitive frailty. Understanding these effects will help us develop intervention models that benefit cognitively frail older adults. The main questions it aims to answer are:
1. Does the combination of iTBS primed with cTBS and aerobic exercise lead to greater improvements in cognition and mobility in older adults with cognitive frailty compared to non-priming iTBS and sham stimulation? 2. What are the neural mechanisms responsible for the improvements in cognition and mobility associated with the combination of iTBS primed with cTBS and aerobic exercise in older adults with cognitive frailty?
Interested in participating?
Request Info60 year–90 year
All sexes
Interventional
Not applicable
Hong Kong
Location status: Recruiting
Objectives: To compare the effects of intermittent theta burst stimulation (iTBS) primed with continuous theta burst stimulation (cTBS), nonpriming iTBS, and sham stimulation on top of aerobic exercise in terms of improving cognitive function, mobility, brain structure, and brain function in older adults with cognitive frailty.
Hypothesis to be tested: We hypothesize that iTBS primed with cTBS can maximize the induction of therapeutically beneficial metaplasticity, and that this will be reflected in improved brain structure and brain function, thereby enabling superior cognitive function and mobility improvement in older adults with cognitive frailty.
Design and subjects: A randomized controlled trial involving 60 older adults with cognitive frailty.
Study instruments: Transcranial magnetic stimulation (TMS) and magnetic resonance imaging (MRI).
Interventions: Participants will be randomly allocated to receive a 39-session intervention with different TBS protocols (i.e., cTBS+iTBS, sham cTBS+iTBS, and sham cTBS+sham iTBS), delivered 3 times per week for 3 months. All participants will receive 60 minutes of aerobic exercise after each stimulation session for 6 months.
Main outcome measures: comprehensive neuropsychological battery covering major executive function (i.e., selective attention/response inhibition, psychomotor speed, set shifting), working memory, and verbal fluency; (2) mobility function evaluated via SPPB, Timed-Up-and-GO (TUG) test, functional gait analysis (i.e., gait speed, gait variability).
Secondary outcomes: underlying neural mechanisms of intervention-induced benefits will be assessed via functional and structural magnetic resonance imaging.
Data analysis: Analysis of variance (ANOVA)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Theta burst stimulation (TBS) will be administered using a figure-of-eight shaped cooling coil (Cool-B65 A/P), which generates auditory "clicks" for sham stimulation that are similar to those produced by active repetitive transcranial magnetic stimulation (rTMS). The placement of the coil will be guided by a navigation system (LOCALITE® TMS Navigator, Germany) using each participant's baseline T1-weighted MRI scans.
TBS is a powerful form of rTMS. Standard 600-pulse intermittent theta burst stimulation (iTBS) can enhance corticomotor excitability, whereas standard 600-pulse continuous theta burst stimulation (cTBS) can suppress it.
The aerobic exercise sessions will include a 10-minute warm-up, followed by 40 minutes of brisk walking and/or stationary exercises without weights, and will conclude with a 10-minute cooldown. The intensity of the aerobic exercise will be monitored using heart rate, starting at 40% of the age-specific heart rate reserve (HRR), which is calculated using the formula: 207 - (0.7 x age). Over the initial 12 weeks, the intensity will be gradually increased until the HRR reaches 65%, and this level will be maintained until the end of the trial.
Time frame: Baseline, 3 months, and 6 months
General cognitive function will be measured by Montreal Cognitive Assessment
Time frame: Baseline, 3 months, and 6 months
Mobility will be measured by Short Physical Performance Battery
Time frame: Baseline, 3 months, and 6 months
The assessment of frailty in older adults will be conducted using the Pictorial Fit-Frail Scale.
Time frame: Baseline, 3 months, and 6 months
The Six Minutes Walking Test is a standard assessment for mobility
Time frame: Baseline, 3 months, and 6 months
The Timed-Up-and-Go Test is a standard assessment for mobility and gait
Time frame: Baseline, 3 months, and 6 months
The Task Switch Test is a standard assessment for executive function
Time frame: Baseline, 3 months, and 6 months
The Digit Span Test is a standard assessment for executive function
Time frame: Baseline, 3 months, and 6 months
The Digit Symbol Substitution Test is a standard assessment for executive function
Time frame: Baseline, 3 months, and 6 months
The Stroop Test is a standard assessment for executive function
Time frame: Baseline, 3 months, and 6 months
The Trail Making Test is a standard assessment for executive function
Time frame: Baseline, 3 months, and 6 months
The Sit to stand is a standard assessment for mobility
Time frame: Baseline, 3 months, and 6 months
Cortical and subcortical volume will be examined in all participants using MRI. Participants will undergo structural MRI on the 3T Siemens scanner at the University Research Facility in Behavioral and Systems Neuroscience. Participants will complete T1 and T2 high resolution anatomical scans.
Time frame: Baseline, 3 months, and 6 months
Participants will be instructed to rest with eyes open for approximately 12 minutes. This will allow the investigators to examine activation in the resting state network.
Time frame: Baseline, 3 months, and 6 months
Physical activity will be assessed by Physical Activity Scale for the Elderly
Time frame: Baseline, 3 months, and 6 months
Depression will be measured by Geriatric Depression Scale
Time frame: Baseline, 3 months, and 6 months
Physical fatigue will be measured by Fatigue Severity Scale
Time frame: Baseline, 3 months, and 6 months
Total number of comorbid conditions will be assessed through the Functional Comorbidity Index
Time frame: Baseline, 3 months, and 6 months
The difficulties in activities of daily living will be assessed using the Functional Activities Questionnaire.
Contact information is provided by the study sponsor or research team.
The Hong Kong Polytechnic University
Other
Acronym: TMS MRI TBS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07220512
Adnexal Diseases, Cognition Disorders
Winston-Salem, North Carolina, United States
View Trial DetailsNCT07616050
Amyotrophic Lateral Sclerosis, Autoimmune Diseases
Bari, Italy
View Trial DetailsNCT07049809
Adherence, Atrophy
Barcelona, Spain
View Trial DetailsNCT07605936
Frailty, Frailty At Older Adults
Limerick, Munster, Ireland
View Trial Details